BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition?

Elena Lomonosova1, Jan Ryerse, G Chinnadurai

  • 1Institute for Molecular Virology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.

Insights

Proteasome inhibitors trigger cancer cell death by increasing BH3-only proteins, initiating apoptosis via the mitochondrial pathway. This mechanism offers a strategy against apoptosis-resistant tumors lacking BAX/BAK proteins.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Proteasome inhibitors are known to induce cancer cell death.
  • The precise mechanisms underlying this cell death, particularly in epithelial cancers, require further elucidation.
  • Understanding the role of apoptosis regulators is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the molecular events leading to cancer cell death induced by proteasome inhibitors.
  • To identify the key proteins and pathways involved in this process.
  • To explore the potential of proteasome inhibitors in overcoming apoptosis resistance.

Main Methods:

  • Treatment of epithelial cancer cells with a proteasome inhibitor (MG132).
  • Analysis of BH3-only protein and p53 levels.
  • Assessment of apoptosis pathway activation, including mitochondrial pathway involvement.
  • Evaluation of BAX and BAK protein function.

Main Results:

  • Proteasome inhibitors caused rapid, simultaneous upregulation of multiple BH3-only proteins (BIK, BIM, MCL-1S, NOXA, PUMA) and p53.
  • Cell death was independent of BAX and likely BAK, proceeding via the intrinsic mitochondrial apoptosis pathway.
  • MG132 induced accumulation of BH3-only proteins in mitochondria, leading to mitochondrial membrane permeabilization and functional impairment.
  • Mitochondrial ultrastructure and network integrity were compromised.

Conclusions:

  • Proteasome inhibitors induce cancer cell death through a BAX/BAK-independent mitochondrial apoptosis pathway, driven by BH3-only protein accumulation.
  • These findings provide a rationale for using proteasome inhibitors to treat apoptosis-resistant tumors lacking functional BAX/BAK.
  • The study elucidates a detailed molecular cascade initiated by proteasome inhibition, highlighting mitochondrial dysfunction as a key outcome.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.